Home
Clinical Trials
Angioplasty or Bypass Surgery...

Angioplasty or Bypass Surgery in Intermittent Claudication

Last Updated: 2010-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

470 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-08-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

CLINICAL TRIAL PROTOCOL SUMMARY / SYNOPSIS

Phase: IV

TITLE OF STUDY

Angioplasty or Bypass Surgery in Intermittent Claudication (ABC-Trial): a randomised controlled trial for patients with complex lesions of the superficial femoral artery

CONDITION

Peripheral arterial occlusive disease (PAOD)

OBJECTIVE(S)

The objective of this study is to evaluate the safety and efficacy of two therapeutic strategies (operative versus endovascular) in the treatment of patients with complex atherosclerotic lesions of the superficial femoral artery.

INTERVENTIONS

Intervention type I: Best endovascular treatment (stent-protected angioplasty). Intervention type II: Best surgical treatment (femoro-popliteal bypass above the knee with autologous vein (1° choice) or a prosthetic graft (if vein is not available).

Duration of intervention per patient: Dependent on the method of treatment

Follow-up per patient: 24 months

OUTCOMES

Primary efficacy endpoint:

Two primary efficacy endpoints will be considered simultaneously in this trial:

(A) Event-free survival (time-to-event endpoint): Proportion (over the course of time) of surviving patients who show a continuing clinical improvement of \>= 1 class (Rutherford classification) without the need for repeated target lesion revascularization (TLR).

(B) Proportion of surviving patients with clinical improvement of \>= 1 class (Rutherford classification) at 24 months after primary intervention (regardless any performed re-intervention).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Balloon Angioplasty vs. Cutting Balloon Angioplasty of Femoropopliteal Arteries- a Randomized Controlled Trial

NCT00437905

Peripheral Vascular Disease Intermittent Claudication Atherosclerosis +1 more

TERMINATED PHASE4

Study of the AFB and Stenting of the Iliac Arteries

NCT02209350

Aorta-iliac Segment Lesion (C,D Type by TASC II)

COMPLETED PHASE1

Trial of Nonsurgical Treatment of Intermittent Claudication Due to Femoro-popliteal Disease

NCT00798850

Femoropopliteal Disease Intermittent Claudication

COMPLETED NA

Allogeneic ABCB5-positive Stem Cells for Treatment of PAOD

NCT03339973

Peripheral Arterial Occlusive Disease

TERMINATED PHASE1/PHASE2

Below Study - Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee

NCT00163254

Patients Above 18 Years

UNKNOWN PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intermittent Claudication Complex Lesions of the Superficial Femoral Artery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Best endovascular treatment

Intervention type I: Best endovascular treatment (stent-protected angioplasty). Intervention type II: Best surgical treatment (femoro-popliteal bypass above the knee with autologous vein (1° choice) or a prosthetic graft (if vein is not available).

Best endovascular treatment or Best surgical treatment

Intervention Type OTHER

Best surgical treatment

Best endovascular treatment or Best surgical treatment

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Best endovascular treatment or Best surgical treatment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is able to verbally acknowledge and understanding of the associated risks, benefits, and treatment alternatives to therapeutic options of this trial. The patients, by providing informed consent, agree to these risks and benefits as stated in the patient informed consent document.
* Patients who are mentally and linguistically able to understand the aim of the study and to show sufficient compliance in following the study protocol.
* Age ≥ 50 and ≤ 85 years old.
* Intermittent claudication (IC) class 2 or 3 (Rutherford) assessed by treadmill testing or 6-Minute Walk Test.
* Lasting \>3 months.
* Failed conservative therapy and the patient's desire for further treatment.
* Atherosclerotic single or multiple stenoses (\>50%) or an occlusion of the Superficial Femoral Artery (SFA) with a target lesion length of 10-20 cm without involvement of the common/deep femoral artery and/or the popliteal artery confirmed by duplex ultrasound and angiography.
* At least one patent tibioperoneal artery with no stenosis \>50% in diameter. Technical and morphological accessibility for both catheter intervention and bypass surgery.
* Absence of other disease that would limit exercise (e.g. angina or chronic respiratory disease).

Exclusion Criteria

* \>50% stenosis or occlusion of the iliac, the common, the deep femoral or the popliteal artery.
* Surgical reconstruction or catheter intervention on the index leg within the last six months.
* Unsuitability of treadmill testing / Six-Minute Walk Test. Chronic limb ischemia (intermittent claudication class 2 to 6) on the contralateral leg.
* Known allergy to contrast agents containing iodine.
* Contraindication for antiplatelet agents or anticoagulants.
* Clinically manifested heart insufficiency (NYHA III, IV) and/or uncorrected hyperthyreosis.
* Serious general disease state with an estimated life expectancy \< 2 years (ASA IV, V).
* Pregnancy

Minimum Eligible Age

50 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers